Literature DB >> 1371716

Elevated expression of pp60c-src in low grade human bladder carcinoma.

P Fanning1, K Bulovas, K S Saini, J A Libertino, A D Joyce, I C Summerhayes.   

Abstract

The results presented in this report demonstrate that the tyrosine-specific protein kinase activity of pp60c-src is elevated over that recorded in normal bladder mucosa in a subset of human bladder carcinomas. Increased kinase activity was observed mainly in low grade bladder lesions and was associated, at least in part, with elevated levels of pp60c-src expression. Extension of this analysis to a panel of human bladder carcinoma cell lines confirmed previous observations of low pp60c-src kinase activity in three lines established from high grade (GIII) bladder tumors and revealed increased kinase activity in three alternative bladder lines derived from GI or GII tumors. Use of an anti-phosphotyrosine antibody in Western blot analysis revealed the presence of novel phosphotyrosyl cellular substrates in human bladder cell lines and tumors displaying elevated pp60c-src kinase activity. These observations suggest an association for the src protooncogene in urothelial cell differentiation events.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371716

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.

Authors:  Sharanjot Saini; Sumit Arora; Shahana Majid; Varahram Shahryari; Yi Chen; Guoren Deng; Soichiro Yamamura; Koji Ueno; Rajvir Dahiya
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

2.  Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.

Authors:  M Loda; P Capodieci; R Mishra; H Yao; C Corless; W Grigioni; Y Wang; C Magi-Galluzzi; P J Stork
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  The expression of c-src gene in the carcinogenesis process of human cardia adenocarcinoma.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Lin Xiao; Xu-Hua Wang; Chao-Jun Wang
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 4.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.

Authors:  Margaret A Knowles; Carolyn D Hurst
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

5.  Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer.

Authors:  Shibu Thomas; Jonathan B Overdevest; Matthew D Nitz; Paul D Williams; Charles R Owens; Marta Sanchez-Carbayo; Henry F Frierson; Martin A Schwartz; Dan Theodorescu
Journal:  Cancer Res       Date:  2010-12-10       Impact factor: 12.701

6.  Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.

Authors:  Yimin Wu; Konstadinos Moissoglu; Hong Wang; Xuejiao Wang; Henry F Frierson; Martin A Schwartz; Dan Theodorescu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-25       Impact factor: 11.205

7.  The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.

Authors:  T Qayyum; G Fyffe; M Duncan; P A McArdle; M Hilmy; C Orange; G Halbert; M Seywright; P G Horgan; M A Underwood; J Edwards
Journal:  Br J Cancer       Date:  2012-02-21       Impact factor: 7.640

8.  Expression and prognostic significance of Src family members in renal clear cell carcinoma.

Authors:  T Qayyum; P A McArdle; G W Lamb; F Jordan; C Orange; M Seywright; P G Horgan; R J Jones; G Oades; M A Aitchison; J Edwards
Journal:  Br J Cancer       Date:  2012-07-19       Impact factor: 7.640

9.  Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.

Authors:  V Boudny; S Nakano
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

10.  Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.

Authors:  K M Rieger; A F Little; J M Swart; W V Kastrinakis; J M Fitzgerald; D T Hess; J A Libertino; I C Summerhayes
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.